WHITEHAWK THERAPEUTICS, INC. (WHWK)

SEC filing

WHITEHAWK THERAPEUTICS, INC.

WHWK · CIK 1422142

4 · Sep 15, 2026 · Director, CHIEF EXECUTIVE OFFICER Lennon David James was granted 387.91K shares

Director, CHIEF EXECUTIVE OFFICER Lennon David James was granted 387.91K shares

xslF345X06/form4-09152026_110953.xml

xslF345X06/form4-09152026_110953.xmlSEC.gov

Graphics and non-inline formats (not embedded below).